Ultrastructural assessment of the infant myocardium receiving crystalloid cardioplegia

Related Experiment Videos

Y Sawa1, H Matsuda, Y Shimazaki

  • 1First Department of Surgery, Osaka University Medical School, Japan.

Circulation
|November 1, 1987
PubMed

Insights

Cold crystalloid potassium cardioplegia did not fully prevent myocardial injury in infants undergoing heart repair. Infants with preoperative heart failure and those under 3 months old showed increased susceptibility to ischemic injury.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Mitochondrial Biology

Background:

  • Pediatric cardiac surgery often requires myocardial protection during procedures.
  • Cold crystalloid potassium cardioplegia is a common method for myocardial protection.
  • Infants represent a unique population with distinct physiological responses to cardiac surgery.

Purpose of the Study:

  • To evaluate the effectiveness of cold crystalloid potassium cardioplegia in preventing myocardial injury in infants undergoing intracardiac repair.
  • To assess factors influencing myocardial susceptibility to ischemic injury in this population.

Main Methods:

  • Myocardial biopsy samples were collected from 26 infants before and after aortic cross-clamping (AXC).
  • Semiquantitative assessment of mitochondrial structure was performed using a scoring system.
  • Patient data including age and preoperative catecholamine support were analyzed.

Main Results:

  • Post-AXC mitochondrial scores were significantly higher than pre-AXC scores, indicating myocardial injury.
  • Patients on preoperative catecholamine support exhibited higher pre- and post-AXC scores.
  • Infants under 3 months old showed significantly higher post-AXC scores compared to older infants.

Conclusions:

  • Cold crystalloid potassium cardioplegia does not fully prevent myocardial injury in infants.
  • Infants with preoperative heart failure and those younger than 3 months are more susceptible to ischemic injury during cardioplegia.
  • Further research into optimized cardioplegia strategies for high-risk infant populations is warranted.

Related Concept Videos